Hi butch1143!
Here is a list of startup companies obtained from Biospace.com
------------------------------------
ActivX Biosciences, Inc.
11025 North Torrey Pines Road, Suite 120
La Jolla, California 92037 U.S.A.
Phone: 858-558-5558 Fax: 858-587-4878
E-Mail: Kathyr@activx.com
http://www.activx.com/
Key Statistics
Industry: Biotechnology
Segment: Assays, Cell Cultures, High-Throughput Screening , Diagnostic
Test Systems , Drug Discovery , Start Up
Ownership: Private
Profile
"ActivX Biosciences, Inc., (www.activx.com), a privately held
biotechnology company in La Jolla, California, is a pioneer in the
field of activity-based proteomics, the identification and analysis of
active proteins key in both normal and disease situations. By focusing
on protein activity, ActivX addresses disease mechanisms directly, in
contrast to standard genomics and proteomics techniques. ActivX
technology includes novel chemical probes integrated with a
high-throughput protein analysis platform to rapidly interrogate the
activities of proteins in all ranges of abundance in any biological
sample, a process it has termed "chemoproteomics". ActivX and its
partners are using its proprietary technology to solve critical
problems in drug discovery and development including identifying novel
drug targets and biomarkers, guiding the medicinal chemistry
optimization of lead compounds through profiling and selectivity
analysis against active proteins in target cells and tissues, and
assessing efficacy and toxicity for candidate and established drugs."
http://www.biospace.com/company_profile.cfm?CompanyID=227204
------------------------------------
AGY Therapeutics, Inc.
290 Utah Avenue
South San Francisco, California 94080 U.S.A.
Phone: 650-615-4530 Fax: 650-615-4544
http://www.agyinc.com/
Key Statistics
Industry: Biotechnology
Segment: Drug Discovery , Start Up
Ownership: Private
Profile
"AGY Therapeutics, Inc. is an emerging biopharmaceutical company
dedicated to the discovery and development of new drugs and drug
targets for the prevention and treatment of diseases of the nervous
system. AGY applies rapid techniques for identifying novel drug
targets and drugs through the delineation of the mechanisms and
critical pathways of pathological CNS processes.
The neuroscience market is the largest pharmaceutical market in the
United States with a high degree of unsatisfied medical need. AGY's
initial focus included Stroke, Alzheimer’s Disease and Parkinson’s
Disease. Other important nervous system diseases that are currently
under investigation for potential novel drug targets for AGY include
depression, anxiety, epilepsy and schizophrenia. AGY has filed
numerous patent applications to protect its conceptual approach and
specific technologies, as well as a large number of target molecules
and potential therapeutics.
The company is assembling an outstanding development program to
augment its discovery programs. Development and discovery programs
will be interwoven to extract maximum information on CNS disease
states and the underlying genetic influences. Methods of identifying
patients who will respond to specific drugs will be developed in
tandem with clinical development.
The founders of AGY are Robert A. Swanson and Karoly Nikolich. Robert
Swanson was the founding CEO of Genentech. Karoly Nikolich, Founder
and Chief Executive Officer, is a leading neuroscientist with many
years of research, leadership and management experience.
http://www.biospace.com/company_profile.cfm?CompanyID=3859
------------------------------------
Alexion Antibody Technologies
11494 Sorrento Valley Road, Suite K
San Diego, California 92121 U.S.A.
Phone: 858-794-6330 Fax: 858-794-6333
E-Mail: kbowdish@alxnsd.com
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Subsidiary
Symbol: ALXN (NASDAQ)
SEC: SEC Filings
Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary
of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and
developing a portfolio of antibody therapeutics targeting severe unmet
medical needs including cancer, autoimmune disorders, and
inflammation.
The discovery program at AAT is based on a proprietary method of
generating human combinatorial antibody libraries, "CoALT" which is
being exploited for the discovery of highly specific fully human
antibody products directed at known clinical targets, and well suited
for ongoing genomic target discovery efforts. Some of these antibodies
may be combined with a novel catalytic antibody technology under
development at AAT, that will link tumor targeting with prodrug
activation for highly specific chemotherapy.
AAT was formed in September 2000 from the merger of the discovery
platform of Prolifaron, Inc with the established antibody development
capacity of Alexion Pharmaceuticals, forming a powerhouse in antibody
discovery and development.
Alexion's two lead antibody product candidates, pexelizumab and
eculizumab are currently in eight clinical development programs. A
Phase III clinical study of pexelizumab is ongoing in cardiopulmonary
bypass patients, and two large Phase II studies are ongoing in acute
myocardial infarction patients. Eculizumab is in a Phase IIb trial for
treatment of rheumatoid arthritis, Phase II trials for treatment of
membranous nephritis and for lupus nephritis, and in earlier stage
clinical trials for treatment of dermatomyositis and pemphigoid.
Alexion is approaching full integration, from discovery through to
commercialization.
http://www.biospace.com/company_profile.cfm?CompanyID=63804
------------------------------------
allvivo, Inc.
20914 Bake Parkway, Suite 112
Lake Forest, California 92630 U.S.A.
Phone: 949-716-6478 E-Mail: pettey@allvivo.com
http://www.allvivo.com/
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Private
Profile
"allvivo develops bio-interactive devices for critical care medicine,
tissue engineering and research. Founded in late 1999, allvivo's
technology (acquired from the University of Utah's Center for
Biopolymers and Interfaces) provides a protective shield between a
device's synthetic surface and the patient's blood and tissue. Beyond
that, therapeutic proteins are incorporated onto the surface of the
device without compromising their biologic activity. As a result, the
surface of the device is more biocompatible with the added capacity to
deliver proteins or mediate therapeutic responses.
The company's lead product candidate incorporates a peptide to
actively down-regulate complement activation, using existing devices,
for patients in septic shock. In the area of tissue engineering and
biological assays, the company is developing environments for cell
growth that mimic the natural settings in the body and prevent
interaction with the underlying surface. allvivo is privately held and
venture-backed with Eno River Capital of North Carolina and Emerging
Technology Partners of Alabama as principal investors."
http://www.biospace.com/company_profile.cfm?CompanyID=247604
------------------------------------
Ambit Biosciences Corporation
9875 Towne Centre Drive
San Diego, California 92121 U.S.A.
Phone: 858-334-2100 Fax: 858-334-2198
http://www.biospace.com/linkto.cfm?link=www.ambitbio.com/
Key Statistics
Industry: Biotechnology
Segment: Drug Discovery , Human Therapeutics , Proteomics , Start Up
Ownership: Private
Employees: 30
Profile
"Ambit Biosciences is a private corporation whose mission is to
develop successful new drugs by identifying and exploiting the unknown
targets of biologically active peptides and small molecules. Using its
proprietary ProteomeScanTM technologies, Ambit discovers novel, yet
validated, drug targets by employing molecules that exert important
biological effects through unknown mechanisms. Ambit identifies these
'drugable' protein targets and develops small molecules and antibodies
that can be used to address important conditions and improve human
health.
Approaches that attempt to address the biological role of expressed
proteins (often termed "proteomics") are difficult, expensive, have
rather low throughput and do not address the fundamental objective of
finding molecules that bind human proteins and modulate activity.
Ambit's approach leap-frogs difficult steps in conventional genomic
and proteomic methods and goes to the heart of the problem by directly
screening a significant fraction of the human proteome, in a parallel,
rapid, efficient and scalable manner, for those proteins that are
bound by biologically active small molecules or peptides. This gives
Ambit the ability to rapidly and efficiently identify therapeutically
relevant drug targets, and provides significant commercial
opportunities.
Ambit's approach to identifying human proteins that bind small
molecules or peptides is based upon the combination of protein display
and affinity chromatography. This proprietary method, termed
ProteomeScanTM, employs a novel twist on conventional phage display
methodology that allows Ambit to interrogate large and diverse
collections of proteins simultaneously. With ProteomeScanTM, Ambit can
directly identify protein targets and clarify mechanisms of action by
the parallel screening of thousands of phage-displayed human proteins
against any chosen molecule."
http://www.biospace.com/company_profile.cfm?CompanyID=460715
------------------------------------
Anadys Pharmaceuticals
9050 Camino Santa Fe
San Diego, California 92121 U.S.A.
Phone: 858-530-3600 E-Mail: hc@anadyspharma.com
http://www.anadyspharma.com./
Key Statistics
Industry: Pharmaceutical
Segment: Drug Discovery , Start Up
Ownership: Private
Profile
"Anadys is an emerging pharmaceutical company that discovers and
develops novel and powerful antibiotics and antivirals. The Company
unites world-class experts in biology and chemistry with an ability to
tackle high-quality targets, including RNA and proteins of unknown
function. Our employee-owners take pride in their projects and the
chance to create in a diverse, non-traditional environment based on
trust, innovation and collaboration. At Anadys you'll find a team
that's really a family, and a company that's really different."
http://www.biospace.com/company_profile.cfm?CompanyID=184604
------------------------------------
AVIVA Biosciences Corporation
11180 Roselle Street, Suite 200
San Diego, California 92121 U.S.A.
Phone: 858-552-0888 Fax: 858-552-9291
E-Mail: info@avivabio.com
http://www.avivabio.com/
Key Statistics
Industry: Biotechnology
Segment: Genomics , Start Up
Ownership: Private
Employees: 22
Profile
"Focus - AVIVA Biosciences Corporation develops drug discovery
technologies by combining biochips with cell biology. Key application
areas include electrophysiology research, ion channel drug screening
and rare-cell enrichment.
About the Company - AVIVA Biosciences specializes in designing and
manufacturing micro-fabricated, multiple force biochips and
consumables. Founded in 1999, AVIVA is addressing the needs of the
pharmaceutical and biotechnology industries and academia by advancing
cell manipulation and sample preparation technologies. These
technologies enable the evolution of novel instrument platforms and
biological assays for automation and improved productivity in cell
based research and diagnostic procedures. AVIVA offers complete
solutions by combining its preparation technologies with partners'
analytical systems. This approach has enabled AVIVA to focus on the
development of biochips and related chemistries. By leveraging the
marketing and sales expertise of its partnering companies, AVIVA will
become the industry standard in biochip solutions.
Product Streams
AVIVA's application-focused technology begins with a targeted function
and customizes its biochips, chemistries, and biological assays to
create optimal solutions.
* AVIVA has developed a SealChipTM single-use disposable cartridge
used exclusively in Axon Instrument's PatchXpressTM 7000A instrument.
PatchXpressTM automates high throughput patch-clamp ion channel
measurements on 16 individual cells in a parallel fashion. The
AVIVA/Axon system is a major advancement in ion channel research,
offering an automated alternative to the slow and labor-intensive
single-cell technique.
* AVIVA's planar patch-clamp SealChipTM positions and seals with a
success rate exceeding 90 percent measuring ion channel currents
rapidly and reproducibly. This advance has been achieved through
in-house breakthroughs in micro-device fabrication and surface
chemistry. SealChipTM provides drug discovery customers a highly
automated ion channel measurement technology for high throughput
screening of drug candidates.
* AVIVA has developed rare cell enrichment technologies for sample
preparation in prenatal screening, cancer diagnostics and therapeutics
and stem cell research. Instruments and proprietary reagents to
automate this procedure are currently in development.
* AVIVA's rare cell sample preparation technologies include
antibodies, magnetic beads and micro-fabricated devices that can
enrich cells by a factor of 100,000 times or more. AVIVA utilizes a
novel micro-filtration chip and protocol that captures up to 90
percent of the rare cells from a blood sample, routinely recovering
even very rare cells (a few 10's to 100's) from 20 mls of blood. "
http://www.biospace.com/company_profile.cfm?CompanyID=228404
------------------------------------
Ceregene, Inc.
9381 Judicial Drive, Suite 130
San Diego, California 92121 U.S.A.
Phone: 858-458-8800 Fax: 858-458-8801
http://www.ceregene.com/
Contact:
Jeffrey M. Ostrove, Ph.D. , President & COO
maito:jostrove@ceregene.com
Key Statistics
Industry: Biotechnology
Segment: Gene Therapy , Human Therapeutics , Life Sciences , Molecular
Biology , Start Up
Ownership: Private
Profile
"Ceregene, Inc., a well-funded start-up company located in San Diego,
California was founded in January 2001. Using gene therapy delivery
systems, Ceregene's primary focus is the discovery and development of
novel genetic therapeutics for the treatment of neurological diseases.
Ceregene aims to be the leader in the field of Central Nervous System
(CNS) disease treatment using molecular medicine.
Neurodegenerative diseases such as Alzheimer's and Parkinson's are the
result of specific cell loss in the brain and scientific data
demonstrates that this cell loss can be prevented by gene-based
therapies that deliver specific neurotrophic factors to the central
nervous system. To date, we have seen substantial, unprecedented
beneficial effects from these therapies in Alzheimer's disease and
Parkinson's disease. Mark Tuszynski, M.D., Ph.D. of the University of
California, San Diego, is currently conducting a physician-sponsored
Phase I clinical study of ex vivo gene therapy in patients with early
stage Alzheimer's disease. Ceregene has the rights to the information
gleaned from this study.
Ceregene's internal focus will be on research and product development
efforts in Alzheimer's and Parkinson's diseases using in vivo gene
delivery technology. In addition, we will be carrying out pre-clinical
development for additional neurodegenerative targets such as
Huntington's disease and Amyotrophic Lateral Sclerosis (ALS).
The combination of proprietary position, research, product development
and clinical expertise will allow Ceregene to develop its CNS gene
therapies into a commercial reality in a broad range of human
diseases."
http://www.biospace.com/company_profile.cfm?CompanyID=366304
------------------------------------
Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco, California 94080 U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010
E-Mail: hr@cytokinetics.com
http://www.cytokinetics.com/
Key Statistics
Industry: Biotechnology , Pharmaceutical
Segment: Drug Discovery , Start Up
Ownership: Private
Profile --
"Cytokinetics was founded in 1998 as a new breed of
cell-biology-driven biopharmaceutical company leveraging novel cell
technologies to accelerate and enhance the productivity of drug
discovery and development. The company's drug discovery and
development programs are focused in the area of cytoskeletal
pharmacology for the identification and development of entirely novel
classes of therapeutic small-molecule compounds in multiple disease
areas, including cancer, cardiovascular disease and anti-microbial
therapeutics. Cytokinetics applies proprietary technologies in the
development of sophisticated multi-protein biochemical assays that
mimic biological function. This broadly applicable high-throughput
screening platform is also integrated with Cytokinetics' automated and
quantitative cell biological phenotyping system to profile attractive
bioactive compounds for further characterization and optimization.
Thus, the company relies on a coupling of advanced biochemical and
novel cellular phenotyping approaches that together are designed to
increase the productivity and speed of the discovery of novel
first-in-class small-molecule therapeutic agents. Cytokinetics has
achieved uncommonly rapid success in translating the pharmaceutical
value of a focus on the cytoskeleton into its first anti-cancer drug
candidate and, with collaboration partner, GlaxoSmithKline, in August
2002 began Phase I studies in the United States. The company's rapidly
emerging small-molecule pipeline covers multiple therapeutic program
areas and is expected to yield one to two additional Investigational
New Drug (IND) filings with the United States FDA in the next twelve
to eighteen months. The company will leverage corporate partnering
activities to ensure broad exploitation of its pipeline opportunities
while retaining rights to develop and commercialize drugs in select
markets tractable to Cytokinetics' resources and capabilities."
http://www.biospace.com/company_profile.cfm?CompanyID=3738
------------------------------------
Cytovia, Inc. (Acquired By Maxim Pharmaceuticals)
6650 Nancy Ridge Drive
San Diego, California 92121 U.S.A.
Phone: 858-860-0500 Fax: 858-860-2300
E-Mail: email@cytovia.com
http://www.cytovia.com/
Key Statistics
Industry: Pharmaceutical
Segment: Drug Discovery , Start Up
Ownership: Subsidiary
Symbol: MAXM (NASDAQ)
"Cytovia is discovering and developing breakthrough therapeutics and
products to assist physicians in combating cancer, the side effects of
current cancer therapeutics, and certain degenerative diseases.
Cytovia’s efforts are focused on finding small molecule drug compounds
that modulate apoptosis, also known as programmed cell death.
Cytovia’s caspase inhibitor program has already identified compounds
which are in pre-clinical development for treatment of acute
myocardial infarction, and to treat chemotherapy-induced oral
mucositis. Additional caspase inhibitor compounds are being developed
for the treatment of other degenerative diseases where cell death is
an issue, such as hepatitis, stroke and sepsis. Cytovia’s caspase
activator program has identified novel therapeutics for the treatment
of drug resistant cancers.
Cytovia is seeking strategic alliances and partnerships that will
allow the company to maximize its growth potential while maintaining
its focus on the Company’s core technology. Using live-cell assays for
High Throughput Screening of potential small molecule therapeutics,
Cytovia has discovered a number of families of caspase modulators,
which cannot all be developed in-house. Cytovia plans to outlicense
rights to the oral mucositis indication in one major geographic area
(North America, Europe, or Japan), while retaining rights in the rest
of the world. Cytovia further plans to out-license its caspase
inhibitors for treatment of myocardial infarction while maintaining a
significant portion of downstream revenues. Cytovia also plans to
out-license anti-cancer lead compounds at various stages of
development. In addition to the above-mentioned programs, Cytovia
plans to outlicense two additional programs each year."
http://www.biospace.com/company_profile.cfm?CompanyID=3503
------------------------------------
Elan Technologies
Palmerston Court
Palmerston Way
London, SW8 4AJ United Kingdom
Phone: 44-020-7498-0222 Fax: +44-020-7840-6222
E-Mail: sales@elan-technologies.com
http://www.elan-technologies.com/
------------------------------------
Genicon Sciences Corporation
11585 Sorrento Valley Road
San Diego, California 92121 U.S.A.
Phone: 858-793-0276 Fax: 858-793-6791
http://www.geniconsciences.com/
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Private
"Genicon Sciences has developed an ultra-sensitive signal generation
and detection system that utilizes resonance light scattering
technology - RLS Technology™ - to meet the needs of scientist and
companies working on microarrays, biochips, genomics, proteomics,
combinatorial chemistry, and high throughput screening (HTS).
Genicon Sciences is focused on three distinct market segments -
research (drug discovery and research), drug development (clinical
trials- Phase I, II, III, IV) and treatment-linked diagnostics (FDA
approved products). Key customers include: university/academic
researchers, pharma and biopharmaceutical companies, genomic and
pharmacogenomic companies, bioanalytical instrumentation and biochip
manufacturers, clinical diagnostic manufacturers, clinical research
organizations (CROs) and reference laboratories.
The company has a comprehensive yet diversified marketing strategy
that allows "open access" to its technology and products, which will
enable emerging genomic, pharmacogenomic and proteomic businesses as
well as facilitate the development of new treatment-linked
diagnostics..."
http://www.biospace.com/company_profile.cfm?CompanyID=158404
------------------------------------
HK Pharmaceuticals, Inc.
6190 Cornerstone Court E., Suite 106
San Diego, California 92121 U.S.A.
Phone: 858-657-9688 Fax: 858-657-9847
E-Mail: info@hkpharma.com
http://www.hkpharmaceuticals.com/
Key Statistics
Industry: Biotechnology , Pharmaceutical
Segment: Drug Discovery , Proteomics , Start Up
Ownership: Private
Employees: 18
Profile --
"HK Pharmaceuticals, Inc. is a privately held drug discovery company
using a proprietary, patented approach to discover and characterize
the therapeutically important protein targets and to develop new,
highly efficient and safe drugs to treat human diseases.
The Company was founded in August 2001 by Hubert Köster, Ph.D., an
internationally renowned biochemist and entrepreneur. Today, in
addition to Dr. Köster, several of the world's leading scientists are
members of HK Pharmaceuticals' scientific board, including Dr. John
Walker, a 1997 Nobel Laureate in Chemistry, and Dr. Franz Hillenkamp,
the inventor of MALDI mass spectrometry. The Company is headquartered
in San Diego, California.
HK Pharmaceuticals has developed a technology that enables significant
advancements in protein separation, analysis, identification and
characterization. The Company is using its technology to discover and
characterize new therapeutically important protein targets, and
subsequently will develop new drugs to respond to those targets. The
key advantages of HK Pharmaceuticals' approach include the ability to
capture and analyze membrane-bound proteins, the deeper understanding
of a target's molecular function, identification of potential toxic
and side effects before expensive clinical trials, and ultimately more
efficient drugs with fewer side effects and faster and less costly
development.
Proprietary Technology --
HK Pharmaceuticals is quickly building its library of proprietary
Capture Compounds™ that separate on demand individual or closely
related proteins from complex biological mixtures, including
membrane-bound proteins, which are involved in critical signaling and
other important pathways, but are elusive for study by today's
analytical methods.
The Company is also building a bank of disease samples and using
in-house cell sorting and tissue culture techniques to replicate their
proteomes, providing medically relevant starting materials.
Proteins that are relevant to the disease demonstrate different
properties in the healthy versus the disease samples. HK
Pharmaceuticals identifies the proteins as known or novel using mass
spectrometry and by comparison with public genome and protein
databases. The Company also uses mass spectrometry to determine the
precise location and identity of amino acid substitutions and
post-translational modifications.
Once a potential drug target is identified and structurally
characterized, HK Pharmaceuticals uses high throughput cell-based
assays to gain deeper insight into its function. Among other steps,
the target's biological function is studied using proprietary,
patented knockin/knockout methods.
HK Pharmaceuticals then screens the targets for interactions with
novel compounds using limited rational design or existing chemical
libraries, resulting in new chemical entities (NCEs) ready for
pre-clinical workup. With a much greater understanding of the target,
the Company is capable of testing for and minimizing toxic drug side
effects before entering clinical trials by iteratively testing the
promising NCEs in cellular environments to ensure that they only
interact with their desired target."
http://www.biospace.com/company_profile.cfm?CompanyID=551020
------------------------------------
Neurome, Inc.
11149 North Torrey Pines Road
La Jolla, California 92037-1031 U.S.A.
Phone: 858-677-0466 Fax: 858-677-0458
E-Mail: info@neurome.com
http://www.neurome.com/
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Private
Employees: 21
Profile --
"Neurome, Inc., develops standardized, quantitative databases that
accurately depict and integrate gene expression patterns in the
3-dimensional context of the brain's structures, circuits and cells,
and deploys these databases in primary research directed toward the
discovery and development of gene targets for enhancement of brain
function and treatment of brain-based disease. Neurome performs
contract brain research for pharmaceutical and biotechnology companies
while at the same time pursuing its own in-house and collaborative
research protocols. The data collected from these efforts will
populate an evolving, comprehensive database available by subscription
and useful on a broad level for analyses of mouse models of brain
function and disease. In this regard, the application of the Neurome
Technologies will provide rigorous, quantitative data that are
optimally suited to the measurement of subtle cell-type specific
shifts in gene expression, as well as progression and prevention of
degenerative events affecting specific cell classes and brain regions.
"
http://www.biospace.com/company_profile.cfm?CompanyID=234904
------------------------------------
Quantum Dot Corporation
26118 Research Road
Hayward, California 94545 U.S.A.
Phone: 510-887-8775 Fax: 510-783-9729
E-Mail: info@qdots.com
http://www.qdots.com/
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Private
Employees: 50
Profile
"ILLUMINATING THE PATH TO SCIENTIFIC DISCOVERY --
Quantum Dot Corporation is commercializing a powerful new tool that is
revolutionizing biological discovery. The company's pioneering work is
predicated on quantum dot (Qdot) particles, tiny semiconductor
crystals developed at Lawrence Berkeley National Laboratory, the
Massachusetts Institute of Technology, University of Melbourne, and
Indiana University.
Critical to pharmaceutical and biological research is the ability to
label, detect, and study biological materials such as DNA, cells, and
proteins. Nanometer-sized QdotTM particles provide massively parallel,
yet simple and inexpensive, solutions for a plethora of biological
research problems in genetic analysis, drug discovery, and
diagnostics.
Qdot particles light up when light is directed at them: put simply,
they glow. Qdot nanocrystals can be used in ways similar to dyes, but
offer numerous advantages due to unusual optical properties. When a
simple blue or ultraviolet light is shined on Qdot crystals-lasers
aren't necessary-they emit any color of choice. Conversely, multiple
dyes typically require light from several lasers, keyed to each color,
which increases cost and assay complexity. In contrast, Qdot particles
can easily label and detect multiple targets simultaneously with
simple, low-cost instruments.
As highly photo-stable encoding agents, water-soluble Qdot particles
can be specifically attached to a spectrum of biological materials
from cells and proteins, to nucleic acids. This 'multiplexing' expands
the range of parameters a scientist can look at concurrently, and
dramatically increases throughput and sensitivity while decreasing
assay costs in life science research.
Quantum Dot was co-founded in November 1998 by accomplished
entrepreneur, former CEO and President of Argonaut Technologies, Joel
Martin, PhD, and entrepreneur and inventor (holder of 25 patents and
founder of Biometric Imaging, and Molecular Dynamics) Bala Manian,
PhD. The company completed second-round financing from preeminent
venture groups in the spring of 2000...."
http://www.biospace.com/company_profile.cfm?CompanyID=199004
------------------------------------ |
Clarification of Answer by
jackburton-ga
on
21 Apr 2003 11:40 PDT
Signature BioScience, Inc.
475 Brannan Street
San Francisco, California 94107 U.S.A.
Phone: 415-490-2400 Fax: 415-490-2434
E-Mail: info@signaturebio.com
http://www.signaturebio.com/
Key Statistics
Industry: Biotechnology
Segment: Drug Discovery , Start Up
Ownership: Private
Profile
"Signature BioScience's unique parallel target and compound selection
platform - WaveScreen™ - is accelerating the drug discovery process by
delivering only the highest quality leads. WaveScreen™ employs the
company's proprietary screening technology, MCS, as well as lead
compound generation and optimization capabilities acquired through the
July 2001 purchase of Cambridge Discovery Chemistry, Inc. The company
intends to globally commercialize its WaveSpec™ instrumentation
through its partnership with MDS Sciex, while internally using
WaveScreen™ to drive lead compound discovery for pharmaceutical and
biotech partners. Formed in late 1998, Signature employs more than 130
engineers, software programmers, biologists, chemists and support
staff in its lab and office facilities in the San Francisco Bay Area.
With more than $64 million in financing to date and an aggressive
partnering strategy, Signature is well positioned to meet our
corporate growth objectives, even in today's challenging market. The
company's instrument partnership with MDS Sciex and four
pharmaceutical collaborations provide meaningful near-term revenue,
while the development of its internal drug discovery capabilities
represent a significant opportunity for medium- and long-term growth.
While still privately-held, Signature's strong cash position allows
the company to continue evaluating opportunities for the acquisition
or in-license of complementary technologies to expand its discovery
capabilities around novel molecular and cellular detection."
http://www.biospace.com/company_profile.cfm?CompanyID=58604
------------------------------------
Sunesis Pharmaceuticals, Inc.
341 Oyster Point Boulevard
South San Francisco, California 94080 U.S.A.
Phone: 650-266-3700 Fax: 650-266-3501
E-Mail: jobs@sunesis.com
http://www.sunesis.com/
Key Statistics
Industry: Pharmaceutical
Segment: Biotechnology , Start Up
Ownership: Private
Profile
"Founded in 1998, Sunesis Pharmaceuticals is a dynamic, pre-IPO
company focused on new methods for the discovery of therapeutic small
molecule drugs. We have put together over 50 world-class scientists in
the fields of protein engineering, structural biology, molecular
modeling, combinatorial and medicinal chemistry, biochemistry, and
cell biology who are actively engaged in highly successful drug
discovery efforts. Our goal is to be a leader in the discovery,
optimization, and early development of pharmaceuticals for the
treatment of major human diseases. We are currently expanding our
research team to exploit a proprietary technology platform based on
the integration of protein engineering and medicinal chemistry.
Sunesis offers a friendly and casual work environment that is
intellectually inspiring and professionally stimulating. We recognize
that motivated employees are central to our success and we are
dedicated to providing rewarding careers and continued opportunity for
advancement. Sunesis values excellent science and thought-provoking
work, and at the same time encourages a balanced work environment with
outstanding benefits."
http://www.biospace.com/company_profile.cfm?CompanyID=4066
------------------------------------
Syrrx, Inc.
10450 Science Center Drive
San Diego, California 92121 U.S.A.
Phone: 858-622-8528 Fax: 858-623-0460
http://www.syrrx.com/
Key Statistics
Industry: Biotechnology
Segment: Drug Discovery , Genomics , Start Up
Ownership: Private
Profile
"Syrrx, Inc. is a leader in the field of structural proteomics. The
company is dedicated to positioning this field as an essential part of
drug discovery in the pharmaceutical industry. Syrrx has created an
automated technology platform that enables the company to determine
protein structures faster and more efficiently than previously
possible. Coupled with Syrrx's drug discovery methods, this technology
will enable the discovery of new drugs with fewer side effects and
greater efficacy. Syrrx is changing the scale of the drug discovery
process in the post-genome age."
http://www.biospace.com/company_profile.cfm?CompanyID=227404
------------------------------------
TargeGen, Inc.
9393 Towne Centre Drive, Suite 120
San Diego, California 92121 U.S.A.
Phone: 858-678-0760 Fax: 858-678-0762
E-Mail: info@targegen.com
http://www.targegen.com/
Key Statistics
Industry: Biopharmaceutical , Biotechnology
Segment: Start Up
Ownership: Private
Employees: 22
Profile
"TargeGen is a privately held San Diego based, vascular biology
company established in July, 2001. TargeGen is developing small
molecule inhibitors that suppress vascular permeability as potential
therapeutics for ischemic diseases including myocardial infarct (MI)
and stroke. These new chemical entities (NCE’s) interact with
biochemical processes associated with vascularization and vascular
permeability. The Company is also developing therapies for the
treatment of certain forms of cancer by co-administration of TargeGen
compounds with certain existing cancer drugs in order to enhance their
effect or limit their toxicities. TargeGen’s access to a large
portfolio of intellectual property through its relationship with Merck
KGaA and to world class expertise in vascular biology positions it to
become a leader in developing next generation therapies...."
http://www.biospace.com/company_profile.cfm?CompanyID=511915
------------------------------------
Triad Therapeutics, Inc.
9381 Judicial Drive, Suite 200
San Diego, California 92121 U.S.A.
Phone: 858-457-0100 Fax: 858-457-7893
E-Mail: info@triadtherapeutics.com
http://www.triadthera.com
Key Statistics
Industry: Biotechnology
Segment: Drug Discovery , Human Therapeutics , Start Up
Ownership: Private
Employees: 60
Profile
"Triad Therapeutics integrates structural biology and medicinal
chemistry to accelerate the discovery and development of potent, small
molecule drugs. The company leverages its expertise in NMR protein
structure analysis and bioinformatics to determine only that
structural information needed to quickly engineer customized,
drug-like, small molecule inhibitors. By using a gene family approach,
where structural information from one protein may be applied to
members of the same family, Triad dramatically shortens the path
between drug target and lead compound identification from two to five
years to about two months.
Triad's development strategy is to license nanomolar inhibitors at
various stages of development. Triad will seek partnerships with
pharmaceutical and biotechnology companies to discover/develop
high-affinity, nanomolar chemical leads. In parallel, Triad will
further develop some inhibitors before partnering. Triad will
initially pursue drug targets classified as cofactor-dependent
enzymes, which contain two binding sites. These targets have utility
across multiple therapeutic areas because these enzyme families, which
include kinases and oxidoreductases, account for approximately 15% of
all proteins.
Pharmaceuticals acting on cofactor-dependent enzymes already exist on
the market. In FY2000, drugs targeting oxidoreductases, which include
the statins commonly used to treat cardiovascular disease, generated
over $20B in sales. Compounds acting against transaminases and
decarboxylases generated sales approaching $1.5B. Another important
class of cofactor-dependent enzymes is the kinase family, which
represents an emerging class of drug targets in the control of cancer
and many chronic diseases. "
http://www.biospace.com/company_profile.cfm?CompanyID=241504
------------------------------------
Virtual Arrays, Inc.
1190 Bordeaux Drive
Sunnyvale, California 94089 U.S.A.
Phone: 408-543-1700 Fax: 408-543-1707
http://www.virtualarrays.com/
Key Statistics
Industry: Biotechnology
Segment: Assays, Cell Cultures, High-Throughput Screening , Start Up
Ownership: Private
Profile
"Virtual Arrays is pioneering a versatile platform technology to
accelerate the discovery of new medicines by transforming the
rate-limiting steps in drug discovery through multi-dimensional
cellular information.
Virtual Arrays' proprietary technology platform addresses one of the
fundamental issues facing the discovery of new biological and small
molecule therapeutics. It is well recognized that the productivity of
putting new candidates into clinical development has not improved
despite significant investment in new technologies. With the large
increase in the number of targets moving from the genome project into
primary screening laboratories, there is a growing need to accelerate
the critical process of converting hits to leads. Virtual Arrays
addresses this problem with a new and powerful technology that enables
highly parallel analysis of information-rich biological readouts.
At the center of Virtual Arrays technology are proprietary CellCardTM,
classes of microcarriers that have unique, identifiable codes, similar
to barcodes. Using CellCard technology and state-of-the-art imaging
capabilities, scientists can evaluate potential new drug candidates
more thoroughly and productively compared to current sequential
methods. The Company's founding team includes biologists and software
engineers with extensive experience with Silicon Valley start-ups. The
Company is backed by Alta Partners, Skyline Ventures, Three Arch
Partners, Sofinnova Ventures and Mediphase Venture Partners."
http://www.biospace.com/company_profile.cfm?CompanyID=332104
------------------------------------
XenoPort, Inc.
3410 Central Expressway
Santa Clara, California 95051 U.S.A.
Phone: 408-616-7200 Fax: 408-616-7210
E-Mail: info@xenoport.com
http://www.xenoport.com/
Key Statistics
Industry: Biopharmaceutical
Segment: Start Up
Ownership: Private
Profile --
"Company Overview - XenoPort, Inc. is an early-stage biopharmaceutical
company that is a leader in development and application of new
technologies to enhance the bioavailability of drugs by exploiting the
function of specific proteins involved in active transport of
molecules into and through cells. Molecular recognition by these
natural transport systems promises to provide a predictable strategy
for drug delivery into cells and across tissue barriers such as the
intestinal epithelium and blood-brain barrier. The powerful tools of
combinatorial chemistry and high-throughput screening, which have
greatly increased the efficiency of compound synthesis and evaluation
in the early stages of drug discovery, are being applied for the first
time to provide mechanism-based solutions to problems of poor drug
bioavailability. XenoPort's initial focus is the exploitation of
transporter proteins for improving the oral absorption of small
molecule, peptide and protein drugs. Orally administered compounds
have traditionally had the greatest potential to achieve blockbuster
commercial status and, in contrast to other delivery strategies, offer
advantages of convenience, improved patient compliance and relatively
low development and usage costs. The medical and business benefits of
effective technology that improves oral bioavailability across
multiple drug classes are enormous. The Company intends to form
relationships with pharma/biotech companies seeking to improve the
oral bioavailablity of their proprietary molecules. In addition, the
Company is applying its technology to compounds with expired patents
to provide newly patented improved medicines..."
http://www.biospace.com/company_profile.cfm?CompanyID=103504
------------------------------------
Zyomyx, Inc.
26101 Research Road
Hayward, California 94545 U.S.A.
Phone: 510-266-7500 Fax: 510-784-2569
E-Mail: info@zyomyx.com
http://www.zyomyx.com
Key Statistics
Industry: Biotechnology
Segment: Start Up
Ownership: Private
Employees: 130
Profile
"Zyomyxis pioneering a versatile platform technology to innovate and
advance proteomics. Zyomyx' approach will, for the first time, bring
to proteomics a highly parallel and high throughput analysis
capability that was essential to the advancement of genomics. The
company has successfully integrated protein biochemistry with advanced
materials science and microfabrication to create the first
miniaturized biochips containing high-density arrays of functional
proteins. This permits thousands of measurements to be conducted on
very small and complex samples. These measurements include protein
concentration, protein structure, protein function, and protein
interactions. The ability to conduct these highly parallel and
sensitive measurements on proteins will play a critical role in the
discovery, development and possibly even the commercialization of a
new generation of drugs. Zyomyx' lead product is the Protein Profiling
biochip designed to identify and validate novel drug targets,
biomarkers, and new therapeutic and diagnostic entities. "
http://www.biospace.com/company_profile.cfm?CompanyID=85204
------------------------------------
|
Clarification of Answer by
jackburton-ga
on
22 Apr 2003 01:01 PDT
Answer (contd) --
------------------------------------
Agility Communications
Agility Communications, Inc.
600 Pine Avenue
Santa Barbara, California
USA 93117
Phone: (805) 690-1700
Fax: (805) 690-1855
Contact: Arlon Martin
Vice President, Sales and Marketing
Email: info@agility.com
http://www.agility.com/
Description - Tunable lasers and optical components
------------------------------------
AirFiber Inc.
AirFiber, Inc.
16510 Via Esprillo
San Diego, CA 92127
http://www.airfiber.com/
Description - Free space optical networking equipment
------------------------------------
All Optical Networks
San Diego, CA
http://www.airfiber.com/
Description - All optical transport multiplexer for the metro access
market
------------------------------------
Arroyo Optics, Inc.
3330 Ocean Park Blvd. Suite 101
Santa Monica, California 90405
310-450-7797 ext. 263
310-450-7091 Fax
John Summers -Vice President of Sales: summers@arroyooptics.com
http://www.arroyooptics.com/
Description - "All-optical" wavelength management solutions
------------------------------------
Astute Networks
16868 Via Del Campo Ct.
San Diego, CA 92127
Telephone (858) 673-7700
Fax (858) 673-7755
E-Mail
General Information: info@astutenetworks.com
Sales: sales@astutenetworks.com
Jobs: jobs@astutenetworks.com
http://www.astutenetworks.com/
Description - Semiconductors offering OC-192 performance and beyond
for Web switches and appliances
------------------------------------
CENiX
C/O Diablo Management Group
25108-B Marguerite Parkway, Box 506
Mission Viejo, CA 92692-2400
Voice Mail: 925-275-0215 x401
Fax: 925-955-1620
http://www.cenixinc.com/
Description - receiver and optoelectronic interfaces for DWDM and
SONET
------------------------------------
Cypherus
95 N. Arroyo Pkwy
Suite 200
Pasadena, CA. 91103
Tel:626-405-1951
Fax:626-405-2308
Email
Sales: sales@cypherus.com
Investor Relations: invest@cypherus.com
http://www.cypherus.com/
Description - Encryption for files, folders and email. File shredder
exceeds DoD standards
------------------------------------
Ellipsis Digital Systems
Carlsbad, CA
http://www.ellipsisdigital.com/
Description - Broadband semiconductors, including an 802.11a/b/g
SoC-embeddable wireless LAN solution.
------------------------------------
Ensemble Communications
9890 Towne Centre Drive
San Diego CA 92121
Tel: +1 858 458 1400
Fax: +1 858 458 1401
Email: ensemble@ensemble.com
http://www.ensemblecom.com/
Description - Broadband Wireless
------------------------------------
entropia
10145 Pacific Heights Blvd., Suite 800
San Diego, CA 92121 USA
Telephone (858) 623-2840
Fax (858) 623-2847
http://www.entropia.com/
Description - Distributed computing across Internet grids of PCs
------------------------------------
eSPACE Technologies Inc
5385, Hollister Avenue
Suite 212, Pacific Technology Center
Santa Barbara, CA 93111
Phone: 805 - 692 9944
Fax: 805 - 964 5685
Email: contactus@espacetech.com
http://www.espacetech.com/
Description - High technology software development company.
------------------------------------
Ethertronics
9605 Scranton Road, Suite 850
San Diego, CA 92121 U.S.A.
Phone: +(1) 858.550.3820
Fax: +(1) 858.550.3821
Email: info@ethertronics.com
http://www.ethertronics.com/
Description - High performance embedded antennas for wireless devices:
Cell Phones, Laptops, WLAN, Telemetry, etc.
------------------------------------
Euvis Inc
31194 La Baya Dr. Suite 107
Westlake Village, CA 91362
USA
Tel: 818-879-7980
Fax: 818-879-9696
E-mail: info@euvis.com
http://www.euvis.com/
Description - Fabless IC design house for broadband communications and
mixed signal ICs
------------------------------------
Excelsus Technologies
2875 Loker Avenue East
Carlsbad, CA 92008-6626
Toll-Free Phone: 800.457.0967
Direct Phone: 760.476.1511
Fax: 760.476.1519
Website URL: www.excelsus-tech.com
Email: info@excelsus-tech.com
Description - DSL filters and testers
------------------------------------
fiberspace
21210 Erwin St., Woodland Hills, CA 91367
Phone: 818-251-1300
email: info@fiberspace.net
http://www.fiberspace.net/
Description - Optical components based on semiconductor laser
technology
------------------------------------
Foundstone
27201 Puerta Real, #400
Mission Viejo, CA 92691
877.91.FOUND
949.297.5600
949.297.5575 | fax
http://www.foundstone.com/
Description - Network-based intrusion protection service
------------------------------------
GTRAN
Corporate Headquarters
2651 Lavery Court
Newbury Park, CA 91320
Phone 805-499-2033
Fax 805-499-2334
Email:info@gtran.com
http://www.gtran.com/
Description - OC-192 and OC-768 transponders, opto-electronic
integrated circuits and optical components
------------------------------------
GTRAN Wireless
1153 Lawrence Drive,
Newbury Park, CA 91320
Tel : 805.375.0999
Fax: 805.375.0339
http://www.gtranwireless.com/
Description - Wireless data products based on 2.5/3G (CDMA, GPRS,
UMTS) and Wi-Fi (802.11b) technologies
------------------------------------
Holoplex Technologies, Inc.
600 South Lake Avenue, Suite 102
Pasadena, California 91106
USA
Tel. +1 626-793-9616 Ext. 1100
Fax +1 626-793-9615
Email: info@holoplex.com
http://www.holoplex.com/
Desription - Enhanced Free Space Optics for wireless communications
links of 1, 2, and 4 km at 155 and 622 Mbps
------------------------------------
Integrated Micromachines Incorporated
Integrated Micromachines, Inc.
1400 S. Shamrock Ave.
Monrovia, CA 91016
[Tel] 626.256.7800
[Fax] 626.256.8400
http://micromachines.com/
Description - MEMS component manufacturing
------------------------------------
Internet Machines
30501 Agoura Road, Suite 203
Agoura Hills, CA 91301
phone: 818.575.2100
fax: 818.575.2105
Email:
info@internetmachines.com for general information
salesinfo@internetmachines.com for sales or detailed product
information
http://www.internetmachines.com/
Description - Highly integrated, protocol-independent network
processor and switch fabric solutions for OC-192 and OC-768 equipment
------------------------------------
Lantelligence
1902 Wright Place Suite 200 Carlsbad, CA 92008
Phone (760) 918-5560
Email: info@lantelligence.com
http://www.lantelligence.com/
Description - Competitive communications applications service provider
offering PBX, ACD, UM on a "hosted" basis.
------------------------------------
LightCross
2630 Corporate Place
Monterey Park, CA 91754
Phone: 626-236-4500
Fax: 626-236-4501
E-mail Contacts
General Information
info@lightcross.com
Sales & Business Development
sales@lightcross.com
http://www.lightcross.com/
Description - Integrated optical components
------------------------------------
LightPointe
10140 Barnes Canyon Rd.
San Diego, CA 92121
+1 858.643.5200 voice
+1 858.643.5201 fax
+1 858.643.5301 sales
http://www.lightpointe.com/
Description - Free space optical systems
------------------------------------
Lumos Technologies
2401 Colorado Ave., Suite 200,
Santa Monica, CA 90404
Tel: 866-655-8667 (toll-free)
310-453-5800
Fax: 310-453-5885
http://www.lumos.com/
Description - DWDM - photonic components
------------------------------------
LYNX Photonic Networks
26775 Malibu Hills Road
Calabasas Hills, CA 91301
Tel: 818-878-7500
Fax: 818-878-7277
http://www.lynx-networks.com/
Description - photonic switching devices and photonic routing
sub-systems
------------------------------------
Magis Networks, Inc.
12651 High Bluff Drive
San Diego, California 92130
Tel: +1 (858) 523-2300
Fax: +1 (858) 523-2301
General Information E-mail: info@magisnetworks.com
Media & Analysts E-mail: media@magisnetworks.com
Employment E-mail: jobs@magisnetworks.com
Investor E-mail: investor@magisnetworks.com
http://www.magisnetworks.com/
Description - 802.11a wireless chipsets
------------------------------------
Mobilian
12707 High Bluff Drive
Suite 335
San Diego, California 92130
Voice: 858-436-2300
Fax: 858-436-2301
http://www.mobilian.com/
Description - Analog and digital integrated circuits and embedded
software for wireless communications
------------------------------------
Nomadix
31355 Agoura Road
Westlake Village, CA 91361
General Inquiries info@nomadix.com +1.818.597.1500
Press & Analyst pr@nomadix.com +1.818.597.1500
Jobs jobs@nomadix.com +1.818.597.1500
http://www.nomadix.com/
Description - broadband subscriber management and service provisioning
gateways
------------------------------------
NxtWave Communications Inc
ATI Technologies Systems Corp.
ATI RESEARCH SILICON VALLEY INC.
2805 Bowers Avenue
Santa Clara, California
U.S.A. 95051-0917
http://www.nxtwavecomm.com/
Description - Wireless
------------------------------------
Occam Networks
77 Robin Hill Road
Santa Barbara, CA 93117
805.692.2900 Main
805.692.2999 Fax
805.692.2911 Customer Support
Email: sales@occamnetworks.com
http://www.occamnetworks.com/
Description - Broadband access network solutions
------------------------------------
Okapi Software, Inc.
18060 Old Coach Drive
Poway, CA 92064
T (858) 613-9341
F (858) 613-9141
info@okapi-software.com.
http://www.okapi-software.com/
Description - iSCSI solutions
------------------------------------
OpVista
OpVista Incorporated
25A Technology Drive
Irvine, CA 92618
Phone: 949.753.8220
Fax: 949.753.8227
http://www.opvista.com/
Description - Long-haul and metro WDM systems
------------------------------------
PacketAir Networks, Inc.
11545 West Bernardo Ct., Suite 100
San Diego, California 92127
Phone: 858.673.6150
Fax: 858.673.6151
Sales / Partnerships / Product Information: info@packetair.com
http://www.packetair.com/
Description - Systems for packet-based mobile wireless networks
------------------------------------
PacketVideo
San Diego, CA
http://www.packetvideo.com/
Description - MPEG-4 codecs for audio/video over wireless
------------------------------------
Peregrine Semiconductor
6175 Nancy Ridge Drive
San Diego, CA 92121
(858) 455-0660 local
(858) 455-0770 fax
http://www.peregrine-semi.com/
Description - 10 Gbps physical layer devices, as well as 6 GHz RF
integrated circuits, based on silicon-on-insulator processing
technology.
------------------------------------
Pharos
411 Amapola Avenue
Torrance, CA 90501-1478
Tel: 310-212-7088
Fax: 310-320-1808
Contacts:
* Product Information/Pre-Sales Inquiries: info@pharosgps.com
* Business Development, OEM Sales: busdev@pharosgps.com
http://www.pharosgps.com/
Description - GPS navigation, telematics and location-centric
applications
------------------------------------
Sabeus Photonics
20630 Nordhoff St.
Chatsworth, CA 91311, USA
Phone: 818-407-6000
Fax: 818-407-6188
General Info: info@sabeus.com
http://www.sabeus.com/
Description - Mode-coupled optical devices, including fiber-based
gain-flattening filters and fiber-based pump laser stabilizers
------------------------------------
Silicon Wave
Silicon Wave, Inc.
6256 Greenwich Drive
Suite 400
San Diego, CA 92122
+1.858.453.9100 tel
+1.858.453.3332 fax
http://www.siliconwave.com/
Description - RF-enabled systems-on-silicon for wireless
------------------------------------
SolarFlare Communications, Inc.
9501 Jeronimo Road, Suite 100
Irvine, CA 92618
Tel: 949.581.6830
Fax: 949.581.4695
Email: info@solarflare.com
http://www.solarflare.com/
Description - Physical layer semiconductors for 10Gbps Ethernet
------------------------------------
Solus Micro Technologies
5706 Corsa Ave.
Westlake Village, CA 91362
http://www.solustech.com/
General Information & Investor Relations
Ike Song - General Manager
Email: isong@solustech.com
Phone: (818) 991-7044 x133
Fax: (818) 991-7128
Description - MEMs-based tunable optical components
------------------------------------
TouchCredit
15 Outrigger Street
Marina Del Rey, CA 90292
(Phone:) 1-310-305-3764
(Fax:) 1-310-577-0262
http://www.touchcredit.net/
Providers of online biometric payment processing solutions
------------------------------------
Tunable Photonics
Tel: 818.251.1300
Email: info@fiberspace.net
http://www.tunablephotonics.com/
Description -
Tunable laser components and technologies
------------------------------------
VSK Photonics
VSK Photonics
100 North Pointe Drive
Lake Forest, California 92630
Phone: 949-586-2202
Fax: 949-586-1199
Customer inquiries & general information, email info@vskphotonics.com
http://www.vskphotonics.com/
Description -
InP semiconductor technology for opto-electronic components
------------------------------------
WIDCOMM
9645 Scranton Rd. Suite 205
San Diego, CA 92121
Tel: 858.453.8400
Fax: 858.453.5735
General Inquiries info@widcomm.com
http://www.widcomm.com/
Description -
Bluetooth protocol software, developer kits, test tools, and network
access points
------------------------------------
Wingcast
San Diego, CA
http://www.wingcast.com/
Description -
A joint venture of Ford and QUALCOMM targerting wireless applications
and telematics services
------------------------------------
Zeros & Ones
1714 16th Street
Santa Monica, CA 90404
310-399-9901
http://www.zerosones.com/
Robert J. Holtz, Chairman & CEO
robert@zerosones.com
Allen Crawford, VP Strategic Development
allen@zerosones.com
Bernie Butler-Smith, VP Advanced Imaging
bernie@zerosones.com
Tim Rummel, VP Managing Director
Zeros & Ones Studios
tim@zerosones.com
Description -
Digital video compression algorithms
------------------------------------
Z-force
Z-force, Inc.
2855 Kifer Rd.
Suite 204
Santa Clara, CA 95051-0822
Phone: (408) 855-1015
Fax: (408) 855-1024
http://www.zforce.com/
email: info@z-force.com or sales@z-force.com
For all advertising and marketing services inquiries, please contact
Sue Stein, Tanis Communications, at 510/507-0350 or sue@taniscomm.com.
Description -
File switch for network-attached storage (NAS) arrays
------------------------------------
Source --
http://www.convergedigest.com/StartupDirectoryX/SouthernCalifornia.asp
|
Clarification of Answer by
jackburton-ga
on
22 Apr 2003 01:53 PDT
Answer (contd) --
Improv Systems
Beverly, MA
http://www.improvsys.com/
Description - Configurable DSPs -- Improv Systems licenses its high
performance, programmable, configurable, scalable, synthesizable VLIW
processors, peripherals, and system-level chip designs to leading
systems and semiconductor manufacturers.
WaveSmith Networks
Acton, MA
http://www.wavesmithnetworks.com/
Description - Next generation multiservice switch supporting ATM,
Frame Relay, TDM/CES and IP services. WaveSmith’s platform will be
built around a distributed optical backplane that scales to 320 Gbps
and hundreds of ports in a single node.
@stake
Cambridge, MA
http://www.atstake.com/
Description - Digital security services
Acme Packet
Woburn, MA
http://www.acmepacket.com/
Description - Net-Net session border controllers for real-time
communications across IP nets; SIP, H.323, MGCP.
Aegis Semiconductor
Lawrence, MA
http://www.aegis-semi.com/
Description - Smart Optics
AmberWave Systems
Salem, NH
http://www.amberwave.com#http//www.amberwave.com/
Description - Strained silicon (epsilon) MOS platform
Appian Communications
Acton, MA
http://www.appiancom.com/
Description - Optical Edge
Arbor Networks
Waltham, MA
http://www.arbornetworks.com/
Description - High availability solutions addressing denial of service
attacks
Artel
Marlborough, MA
http://www.artel.tv/
Description - MPEG digital video networking systems for delivery over
ATM networks
Authentica
Waltham, MA
http://www.authentica.com/
Description - Digital rights management software
Axcel Photonics
Marlboro, MA
http://www.axcelphotonics.com/
Description - Active components
AXSUN Technologies
Billerica, MA
http://www.axsun.com/
Description - Packaging platform for hybrid photonic products
Bizfon
Salem, NH
http://www.bizfon.com/
Description - new office PBX systems
Brix Networks
Chelmsford, MA
http://www.brixnetworks.com/
Description - Service Level Agreement verification software for IP
networks
Cedar Point Communications
Derry, NH
http://www.cedarpointcom.com/
Description - PacketCable compliant CMSS (Cable Media Switching
System).
Charlotte's Web Networks
Andover, MA and Yokneam, Israel
http://www.cwnt.com/
Description - Terabit routing platforms
CiDRA
Wallingford, CT
http://www.cidra.com/
Description - tunable photonic components and subsystems
Clarendon Photonics
Boston, MA
http://www.clarendonphotonics.com/
Description - Single chip, multi-functional optical components based
on planar lightwave technology
Confluent Photonics
Andover, MA
http://www.confluentphotonics.com/
Description - Wafer-scale integrated optical components for DWDM
applications
Continuum Photonics
Billerica, MA
http://www.continuumphotonics.com/
Description - Optical networking components and subsystems, including
optical switches
Convergent Networks
Lowell, MA
http://www.convergentnet.com/
Description - Voice - Data Integration
Conversent Communications
Marlboro, MA
http://www.conversent.com/
Description - facilities-based CLEC
Coriolis
Boxborough, MA
http://www.coriolisnet.com/
Description - metro optical products
Crossbeam Systems
Concord, MA
http://www.crossbeamsystems.com/
Description - network application concentrator for data centers
Cyber-Ark Software
Dedham, MA and Lod, Israel
http://www.cyber-ark.com/
Description - 10 layers of network security, including VPNs,
firewalls, file access control, encryption, authentication
Egenera
Marlboro, MA
http://www.egenera.com/
Description - Processing Area Network (PAN) Architecture for Internet
data centers
Ellacoya
Merrimack, NH
http://www.ellacoya.com/
Description - IP services platform
Ember Corporation
Cambridge, MA
http://www.embercorp.com/
Description - Wireless embedded networking platform
Emperative
Waltham, MA
http://www.emperative.com/
Description - Automated carrier-class service provisioning software
Empirix
Waltham, MA
http://www.empirix.com/
Description - Test and monitoring solutions for Web and voice apps,
contact centers and networks
Envoy Networks
Billerica, MA
http://www.envoynetworks.com/
Description - equipment for 3G wireless services
Equipe Communications
Acton, MA
http://www.equipecom.com/
Description - Optical edge solutions
Fiber Optic Network Solutions
Northboro, MA
http://www.fons.com/
Description - passive optical components and interconnect solutions
GeoTrust
Wellesley Hills, MA
http://www.geotrust.com/
Description - Internet identity, authentication and risk assessment
solutions, including XML-based credentials
GiantLoop Network
Waltham, MA
http://www.giantloop.com/
Description - Enterprise optical networking service provider
Gold Wire Technology
Waltham, MA
http://www.goldwiretech.com/
Description - Software that allows ISPs to control and manage Internet
configuration
Granite Systems
Manchester, NH
http://www.granite.com/
Description - network configuration management
HeliOss Communications
Waltham, MA and Israel
http://www.helioss.com/
Description - wireless broadband
Hittite Microwave
Chelmsford, MA
http://www.hittite.com/
Description - Integrated circuit products for wireless communications
Howe Digital
Westford, MA
http://www.howedigital.com/
Description - VoIP software
ideaLogix
Framingham, MA
http://www.idealogix.com/
Description - Wireless monitoring and control systems for enterprise
networks
IneoQuest Technologies
Mansfield, MA
http://www.ineoquest.com/
Description - Network Traffic Stimulus, Capture and Analysis
Systems.Gigabit, 10 Gigabit, OC-192, OC-48
InfiniSwitch
Westborough, MA
http://www.infiniswitch.com/
Description - InfiniBand switching technology
Infinite Photonics
Warwick, RI
http://www.infinite-group.com/
Description - optoelectronic modules designed for short-reach
interconnects between IP switching/routing equipment
InfoLibria
Waltham, MA
http://www.infolibria.com/
Description - Network caches
Integral Access
Chelmsford, MA
http://www.integralaccess.com/
Description - Multi-service access platforms
Into Networks
Cambridge, MA
http://www.intonet.com/
Description - on-demand software distribution system
InvisibleHand Networks
Burlington, MA
http://www.invisiblehand.net/
Description - Technology for real-time automated IP bandwidth trading
IPeria
Burlington, MA
http://www.iperia.com/
Description - distributed software platform for IP voice activated
voice e-mail, Internet event alerting, e-mail and voice mail
Kada Systems
Burlington, MA
http://www.kadasystems.com/
Description - Java Virtual Machine platform for handheld mobile
devices
Kenetec
Naugatuck, CT
http://www.kenetec.com/
Description - Broadband access systems for multi-tenant unit (MTU)
facilities
kSARIA Corp.
Wilmington, MA
http://www.ksaria.com/
Description - Automated optical component assembly technologies
LaserSharp
Hopkinton, MA
http://www.lasersharpcorp.com/
Description - Photonic modules and subsystems for the optical
communications infrastructure
Lexra
San Jose, CA and Waltham, MA
http://www.lexra.com/
Description - System-on-chip (SOC) processor cores
Litchfield Communications
Watertown, CT
http://www.litchfieldcomm.com/
Description - Standards-based semiconductor technology, reference
designs, and support software for the next-generation of networking
equipment.
LiveVault Corporation
Marlboro, MA
http://www.livevault.com/
Description - IP online backup and recovery service for server data
protection
Mazu Networks
Cambridge, MA
http://www.mazunetworks.com/
Description - Preemptive solutions for Distributed Denial of Service
(DDoS) attacks
MessageMachines
Boston, MA
http://www.messagemachines.com/
Description - System that transfers a variety of message formats
between real-time communications devices and systems
MetaTel, Inc.
Waltham, MA
http://www.metatel.com/
Description - PC-based telephony management systems
MetraTech
Waltham, MA
http://www.metratech.com/
Description - XML-based billing, customer care and revenue sharing
software for service providers
METRObility Optical Systems
Merrimack, NH
http://www.metrobility.com/
Description - Network edge access and last mile connectivity solutions
for metro optical Ethernet. Provisioning platforms and management
systems facilitate deployment of existing fiber and copper
infrastructure.
Mintera Optical Networks
Lowell, MA
http://www.mintera.com/
Description - 40 Gbps solutions for long-haul DWDM and metro networks
Narad Networks
Westford, MA
http://www.naradnetworks.com/
Description - Access platform and service-enabling environment for IP
over existing HFC networks
Nauticus Networks
Framingham, MA
http://www.nauticusnet.com/
Description - Internet infrastructure products
Navic Networks
Newton, MA
http://www.navic.tv/
Description - data tracking systems for digital set-top boxes
NetNumber
Lowell, MA
http://www.netnumber.com/
Description - ENUM-compliant directory services and support systems to
the Internet telephony industry
Netonomy
Paris Paris, France and Boston, MA
http://www.netonomy.com/
Description - Customer self-service account management application
platform for wireless communications service providers
NTRU
Burlington, MA
http://www.ntru.com
Description - High-performance public-key cryptographic security for
consumer devices and mobile phones
Nufern
Weatogue, CT
http://www.nufern.com/
Description - Specialty optical fibers for DWDM
OmniGuide Communications
Cambridge, MA
http://www.omni-guide.com/
Description - hollow-core optical fiber
ONEX Communications
Bedford, MA
http://www.onexco.com/
Description - Fabless semiconductor company creating switching and
transmission infrastructure products for multi-service access networks
OpenReach
Woburn, MA
http://www.openreach.com/
Description - IPsec & SSL VPN integrated managed service solutions
over any Internet or private IP infrastructure
Optix Networks
Stoneham, MA and Tel-Aviv, Israel
http://www.optixnetworks.com/
Description - optical networks
Pactolus Communication Software
Westborough, MA
http://www.pactolus.com/
Description - XML-based service platforms, applications and service
creation solutions for SIP-enabled networks
Paragon Networks
Brookfield, CT
http://www.paragon-networks.com/
Description - Data transmission equipment for wireless service
providers
Passlogix
New York, NY
http://www.passlogix.com/
Description - Single sign-on (SSO) software
Pelago Networks
Marlborough, MA
http://www.pelagonet.com/
Description - service creation and delivery products
PhotonEx
Maynard, Mass
http://www.photonex.com/
Description - Optical platform for network backbones
Pingtel
Woburn, MA
http://www.pingtel.com/
Description - SIP-based communications products, including IP voice
systems and Java-smart desk and PC SIP phones
ProQuent Systems
Marlborough, MA
http://www.proquent.com/
Description - Mobile networking infrastructure equipment
Quallaby
Lowell, MA
http://www.quallaby.com/
Description - Network management software
Quantum Bridge Communications, Inc.
North Andover, MA
http://www.quantumbridge.com/
Description - Optical Networking
Quarry Technologies
Burlington, MA
http://www.quarrytech.com/
Description - IP edge switches for service provisioning
RF Integration Inc.
Lowell, MA
http://www.rfintegration.com/
Description - Highly Integrated Chipsets for the Wireless and Broadand
Communications market
Sandburst
Andover, MA
http://www.sandburst.com/
Description - 10 Gbps chipsets
Sheer Networks
Framingham, MA and Sunnyvale, CA
http://www.sheernetworks.com/
Description - Broadband network service management
Sitara Networks
Waltham, MA
http://www.sitaranetworks.com/
Description - QoS tools for monitoring and optimizing network traffic
patterns
Snowshore Networks
Chelmsford, MA
http://www.snowshore.com/
Description - Media server for delivery of integrated Web content and
real-time interactive voice communications
Sockeye Networks
Newton, MA
http://www.sockeye.com/
Description - Routing solutions that combine real-time data on global
Internet conditions with proprietary local IP traffic information
Starent Networks
Tewksbury, MA
http://www.starentnetworks.com/
Description - Wireless packet platform for 2.5 and 3G mobile operators
StarGen
Marlborough, MA
http://www.stargen.com/
Description - Components & SW for StarFabric Switched Interconnect for
comm. and embedded applications
Stargus
Andover, MA
http://www.stargus.com/
Description - Real-time monitoring and automated management system for
DOCSIS networks
Storigen Systems
Lowell, MA
http://www.storigen.com/
Description - Distributed storage systems
Taqua Systems
Hyannis, MA
http://www.taqua.com/
Description - Switching system with integrated softswitch
functionality
Taral Networks
Lexington, MA
http://www.taralnetworks.com/
Description - Network infrastructure for wireless operators offering
content messaging
Telica
Marlboro, MA
http://www.telica.com/
Description - Softswitch-based voice and data infrastructure products
TeraConnect
Nashua, NH
http://www.teraconnect.com/
Description - Components for optical networking systems
Terago Communications
Andover, MA
http://www.terago.com/
Description - Networks processors for 10 Gbps and 40 Gbps
Tiaris
Concord, MA
http://www.tiaris.com/
Description - System-on-chip solutions for home networking
Trebia Networks
Acton, MA
http://www.trebia.com/
Description - Storage network processors
VBrick Systems
Wallingford, CT
http://www.vbrick.com/
Description - MPEG1 and MPEG2 codecs
Verrillon, Inc.
Grafton, MA
http://www.verrillon.com/
Description - Specialty optical fiber for telecom, defense, and
geophysical markets
Voltaire Inc.
Bedford, MA and Herzlia, Israel
http://www.voltaire.com/
Description - InfiniBand routing solutions
WaterCove Networks
Chelmsford, MA
http://www.watercove.com/
Description - Mobile data architecture for IP applications and
services
Winphoria
Tewksbury, MA
http://www.winphoria.com/
Description - Mobile wireless switching system
Wireless Bypass
Salem, NH
http://www.wireless-bypass.com/
Description - Private Broadband Wireless Access Products
Xelerated
Burlington, MA
http://www.xelerated.com/
Description - Programmable 10G NPUs-10x the processing efficiency of
RISC NPUs and bandwidth efficiency of an ASIC
Xevo
Marlborough, MA
http://www.xevo.com/
Description - delivers coordinated, scaleable application services
------------------------------------
Source --
http://www.convergedigest.com/StartupDirectoryX/NewEngland.asp
------------------------------------
Sorry for the multiple postings...
- I hope this is the information you wanted
regards,
Jack
|
